Filing Flows › Envoy Medical (COCH) › Q2 2026
Envoy Medical (COCH) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 10, 2026
Envoy Medical (COCH) reported revenue of $51K for the second quarter 2026 (Q2 2026), -35% from a year earlier and +31% from the quarter before.
Envoy Medical, Q2 2026: revenue $51K (-35% year over year), net loss $6.0M, operating cash flow −$5.5M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $51K | +31% | -35% |
| Operating profit | −$5.6M | — | — |
| Net earnings | −$6.0M | — | — |
| Operating cash flow | −$5.5M | — | — |
What changed
Revenue was $51K in Q2 2026, down 35% year over year and up 31% from the previous quarter.
Operating costs exceeded revenue by $5.6M, an operating margin of -10919.6%. Total costs grew 9% against a revenue fall of 35%. The fastest-growing cost line was Research & development (+26%). The quarter ended with a net loss of $6.0M, wider than the previous quarter's $4.4M loss.
Operating cash flow was −$5.5M. Non-cash charges added back $74K of depreciation and $214K of share-based compensation.
Questions
What was Envoy Medical's revenue in the second quarter 2026?
Envoy Medical (COCH) reported revenue of $51K for the second quarter 2026 (Q2 2026), -35% from a year earlier and +31% from the quarter before.
Source: Envoy Medical 10-Q on SEC EDGAR.